1. Home
  2. IMXI vs PCRX Comparison

IMXI vs PCRX Comparison

Compare IMXI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$15.40

Market Cap

458.3M

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.36

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
PCRX
Founded
1994
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
458.3M
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
IMXI
PCRX
Price
$15.40
$26.36
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$16.67
$32.86
AVG Volume (30 Days)
212.3K
857.0K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.29
0.47
Revenue
$625,123,000.00
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
$0.95
$9.53
P/E Ratio
$11.96
$56.25
Revenue Growth
N/A
3.14
52 Week Low
$8.58
$18.17
52 Week High
$21.41
$27.64

Technical Indicators

Market Signals
Indicator
IMXI
PCRX
Relative Strength Index (RSI) 60.57 62.13
Support Level $15.36 $25.56
Resistance Level $15.43 $27.16
Average True Range (ATR) 0.06 0.98
MACD -0.02 0.00
Stochastic Oscillator 36.84 75.47

Price Performance

Historical Comparison
IMXI
PCRX

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: